Beta Bionics to Integrate iLet Bionic Pancreas with Abbott's Future Dual Sensor
I'm PortAI, I can summarize articles.
Beta Bionics, Inc. has announced a partnership with Abbott to integrate its iLet Bionic Pancreas with Abbott’s upcoming dual glucose-ketone sensor in the U.S. This collaboration aims to enhance diabetes management by automating insulin dosing and eliminating the need for carb counting. The partnership builds on their existing work with the FreeStyle Libre® 3 Plus sensor, emphasizing their commitment to improving real-time decision-making support for diabetes care.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments